Global Pet Veterinary Drug Market Growth 2025-2031
The global Pet Veterinary Drug market size is predicted to grow from US$ 9704 million in 2025 to US$ 13070 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.
LP Information, Inc. (LPI) ' newest research report, the “Pet Veterinary Drug Industry Forecast” looks at past sales and reviews total world Pet Veterinary Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Veterinary Drug sales for 2025 through 2031. With Pet Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Veterinary Drug industry.
This Insight Report provides a comprehensive analysis of the global Pet Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Veterinary Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Veterinary Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Veterinary Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pet Veterinary Drug market?
What factors are driving Pet Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Veterinary Drug market opportunities vary by end market size?
How does Pet Veterinary Drug break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.
LP Information, Inc. (LPI) ' newest research report, the “Pet Veterinary Drug Industry Forecast” looks at past sales and reviews total world Pet Veterinary Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Veterinary Drug sales for 2025 through 2031. With Pet Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Veterinary Drug industry.
This Insight Report provides a comprehensive analysis of the global Pet Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Veterinary Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Veterinary Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Veterinary Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
- Veterinary Hospitals
- Veterinary Clinics
- Drug Stores
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim International GmbH
- Zoetis Animal Healthcare
- Bayer AG
- Merck Animal Health
- Elanco Animal Health Inc.
- Virbac Group
- Ceva
- Dechra Pharmaceuticals Plc
- Vetoquinol
- Orion Corporation
What is the 10-year outlook for the global Pet Veterinary Drug market?
What factors are driving Pet Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Veterinary Drug market opportunities vary by end market size?
How does Pet Veterinary Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Veterinary Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pet Veterinary Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pet Veterinary Drug by Country/Region, 2020, 2024 & 2031
2.2 Pet Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Pet Veterinary Drug Sales by Type
2.3.1 Global Pet Veterinary Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Pet Veterinary Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pet Veterinary Drug Sale Price by Type (2020-2025)
2.4 Pet Veterinary Drug Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Drug Stores
2.5 Pet Veterinary Drug Sales by Application
2.5.1 Global Pet Veterinary Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Pet Veterinary Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pet Veterinary Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pet Veterinary Drug Breakdown Data by Company
3.1.1 Global Pet Veterinary Drug Annual Sales by Company (2020-2025)
3.1.2 Global Pet Veterinary Drug Sales Market Share by Company (2020-2025)
3.2 Global Pet Veterinary Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Pet Veterinary Drug Revenue by Company (2020-2025)
3.2.2 Global Pet Veterinary Drug Revenue Market Share by Company (2020-2025)
3.3 Global Pet Veterinary Drug Sale Price by Company
3.4 Key Manufacturers Pet Veterinary Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Veterinary Drug Product Location Distribution
3.4.2 Players Pet Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET VETERINARY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Pet Veterinary Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Pet Veterinary Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pet Veterinary Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pet Veterinary Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Pet Veterinary Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pet Veterinary Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pet Veterinary Drug Sales Growth
4.4 APAC Pet Veterinary Drug Sales Growth
4.5 Europe Pet Veterinary Drug Sales Growth
4.6 Middle East & Africa Pet Veterinary Drug Sales Growth
5 AMERICAS
5.1 Americas Pet Veterinary Drug Sales by Country
5.1.1 Americas Pet Veterinary Drug Sales by Country (2020-2025)
5.1.2 Americas Pet Veterinary Drug Revenue by Country (2020-2025)
5.2 Americas Pet Veterinary Drug Sales by Type (2020-2025)
5.3 Americas Pet Veterinary Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Veterinary Drug Sales by Region
6.1.1 APAC Pet Veterinary Drug Sales by Region (2020-2025)
6.1.2 APAC Pet Veterinary Drug Revenue by Region (2020-2025)
6.2 APAC Pet Veterinary Drug Sales by Type (2020-2025)
6.3 APAC Pet Veterinary Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Veterinary Drug by Country
7.1.1 Europe Pet Veterinary Drug Sales by Country (2020-2025)
7.1.2 Europe Pet Veterinary Drug Revenue by Country (2020-2025)
7.2 Europe Pet Veterinary Drug Sales by Type (2020-2025)
7.3 Europe Pet Veterinary Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Veterinary Drug by Country
8.1.1 Middle East & Africa Pet Veterinary Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pet Veterinary Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Pet Veterinary Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Pet Veterinary Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Veterinary Drug
10.3 Manufacturing Process Analysis of Pet Veterinary Drug
10.4 Industry Chain Structure of Pet Veterinary Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Veterinary Drug Distributors
11.3 Pet Veterinary Drug Customer
12 WORLD FORECAST REVIEW FOR PET VETERINARY DRUG BY GEOGRAPHIC REGION
12.1 Global Pet Veterinary Drug Market Size Forecast by Region
12.1.1 Global Pet Veterinary Drug Forecast by Region (2026-2031)
12.1.2 Global Pet Veterinary Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pet Veterinary Drug Forecast by Type (2026-2031)
12.7 Global Pet Veterinary Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim International GmbH
13.1.1 Boehringer Ingelheim International GmbH Company Information
13.1.2 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim International GmbH Main Business Overview
13.1.5 Boehringer Ingelheim International GmbH Latest Developments
13.2 Zoetis Animal Healthcare
13.2.1 Zoetis Animal Healthcare Company Information
13.2.2 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolios and Specifications
13.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Animal Healthcare Main Business Overview
13.2.5 Zoetis Animal Healthcare Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Pet Veterinary Drug Product Portfolios and Specifications
13.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Pet Veterinary Drug Product Portfolios and Specifications
13.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Elanco Animal Health Inc.
13.5.1 Elanco Animal Health Inc. Company Information
13.5.2 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolios and Specifications
13.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Elanco Animal Health Inc. Main Business Overview
13.5.5 Elanco Animal Health Inc. Latest Developments
13.6 Virbac Group
13.6.1 Virbac Group Company Information
13.6.2 Virbac Group Pet Veterinary Drug Product Portfolios and Specifications
13.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Virbac Group Main Business Overview
13.6.5 Virbac Group Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Veterinary Drug Product Portfolios and Specifications
13.7.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Dechra Pharmaceuticals Plc
13.8.1 Dechra Pharmaceuticals Plc Company Information
13.8.2 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolios and Specifications
13.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Dechra Pharmaceuticals Plc Main Business Overview
13.8.5 Dechra Pharmaceuticals Plc Latest Developments
13.9 Vetoquinol
13.9.1 Vetoquinol Company Information
13.9.2 Vetoquinol Pet Veterinary Drug Product Portfolios and Specifications
13.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Vetoquinol Main Business Overview
13.9.5 Vetoquinol Latest Developments
13.10 Orion Corporation
13.10.1 Orion Corporation Company Information
13.10.2 Orion Corporation Pet Veterinary Drug Product Portfolios and Specifications
13.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Orion Corporation Main Business Overview
13.10.5 Orion Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Veterinary Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pet Veterinary Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pet Veterinary Drug by Country/Region, 2020, 2024 & 2031
2.2 Pet Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Pet Veterinary Drug Sales by Type
2.3.1 Global Pet Veterinary Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Pet Veterinary Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pet Veterinary Drug Sale Price by Type (2020-2025)
2.4 Pet Veterinary Drug Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Drug Stores
2.5 Pet Veterinary Drug Sales by Application
2.5.1 Global Pet Veterinary Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Pet Veterinary Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pet Veterinary Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pet Veterinary Drug Breakdown Data by Company
3.1.1 Global Pet Veterinary Drug Annual Sales by Company (2020-2025)
3.1.2 Global Pet Veterinary Drug Sales Market Share by Company (2020-2025)
3.2 Global Pet Veterinary Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Pet Veterinary Drug Revenue by Company (2020-2025)
3.2.2 Global Pet Veterinary Drug Revenue Market Share by Company (2020-2025)
3.3 Global Pet Veterinary Drug Sale Price by Company
3.4 Key Manufacturers Pet Veterinary Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Veterinary Drug Product Location Distribution
3.4.2 Players Pet Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET VETERINARY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Pet Veterinary Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Pet Veterinary Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pet Veterinary Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pet Veterinary Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Pet Veterinary Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pet Veterinary Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pet Veterinary Drug Sales Growth
4.4 APAC Pet Veterinary Drug Sales Growth
4.5 Europe Pet Veterinary Drug Sales Growth
4.6 Middle East & Africa Pet Veterinary Drug Sales Growth
5 AMERICAS
5.1 Americas Pet Veterinary Drug Sales by Country
5.1.1 Americas Pet Veterinary Drug Sales by Country (2020-2025)
5.1.2 Americas Pet Veterinary Drug Revenue by Country (2020-2025)
5.2 Americas Pet Veterinary Drug Sales by Type (2020-2025)
5.3 Americas Pet Veterinary Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Veterinary Drug Sales by Region
6.1.1 APAC Pet Veterinary Drug Sales by Region (2020-2025)
6.1.2 APAC Pet Veterinary Drug Revenue by Region (2020-2025)
6.2 APAC Pet Veterinary Drug Sales by Type (2020-2025)
6.3 APAC Pet Veterinary Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Veterinary Drug by Country
7.1.1 Europe Pet Veterinary Drug Sales by Country (2020-2025)
7.1.2 Europe Pet Veterinary Drug Revenue by Country (2020-2025)
7.2 Europe Pet Veterinary Drug Sales by Type (2020-2025)
7.3 Europe Pet Veterinary Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Veterinary Drug by Country
8.1.1 Middle East & Africa Pet Veterinary Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pet Veterinary Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Pet Veterinary Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Pet Veterinary Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Veterinary Drug
10.3 Manufacturing Process Analysis of Pet Veterinary Drug
10.4 Industry Chain Structure of Pet Veterinary Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Veterinary Drug Distributors
11.3 Pet Veterinary Drug Customer
12 WORLD FORECAST REVIEW FOR PET VETERINARY DRUG BY GEOGRAPHIC REGION
12.1 Global Pet Veterinary Drug Market Size Forecast by Region
12.1.1 Global Pet Veterinary Drug Forecast by Region (2026-2031)
12.1.2 Global Pet Veterinary Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pet Veterinary Drug Forecast by Type (2026-2031)
12.7 Global Pet Veterinary Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim International GmbH
13.1.1 Boehringer Ingelheim International GmbH Company Information
13.1.2 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim International GmbH Main Business Overview
13.1.5 Boehringer Ingelheim International GmbH Latest Developments
13.2 Zoetis Animal Healthcare
13.2.1 Zoetis Animal Healthcare Company Information
13.2.2 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolios and Specifications
13.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Animal Healthcare Main Business Overview
13.2.5 Zoetis Animal Healthcare Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Pet Veterinary Drug Product Portfolios and Specifications
13.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Pet Veterinary Drug Product Portfolios and Specifications
13.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Elanco Animal Health Inc.
13.5.1 Elanco Animal Health Inc. Company Information
13.5.2 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolios and Specifications
13.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Elanco Animal Health Inc. Main Business Overview
13.5.5 Elanco Animal Health Inc. Latest Developments
13.6 Virbac Group
13.6.1 Virbac Group Company Information
13.6.2 Virbac Group Pet Veterinary Drug Product Portfolios and Specifications
13.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Virbac Group Main Business Overview
13.6.5 Virbac Group Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Veterinary Drug Product Portfolios and Specifications
13.7.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Dechra Pharmaceuticals Plc
13.8.1 Dechra Pharmaceuticals Plc Company Information
13.8.2 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolios and Specifications
13.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Dechra Pharmaceuticals Plc Main Business Overview
13.8.5 Dechra Pharmaceuticals Plc Latest Developments
13.9 Vetoquinol
13.9.1 Vetoquinol Company Information
13.9.2 Vetoquinol Pet Veterinary Drug Product Portfolios and Specifications
13.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Vetoquinol Main Business Overview
13.9.5 Vetoquinol Latest Developments
13.10 Orion Corporation
13.10.1 Orion Corporation Company Information
13.10.2 Orion Corporation Pet Veterinary Drug Product Portfolios and Specifications
13.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Orion Corporation Main Business Overview
13.10.5 Orion Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet Veterinary Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pet Veterinary Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-Infectives
Table 4. Major Players of Anti-Inflammatory
Table 5. Major Players of Parasiticides
Table 6. Major Players of Analgesics
Table 7. Major Players of Sedatives
Table 8. Major Players of Others
Table 9. Global Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 10. Global Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Table 11. Global Pet Veterinary Drug Revenue by Type (2020-2025) & ($ million)
Table 12. Global Pet Veterinary Drug Revenue Market Share by Type (2020-2025)
Table 13. Global Pet Veterinary Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Pet Veterinary Drug Sale by Application (2020-2025) & (K Units)
Table 15. Global Pet Veterinary Drug Sale Market Share by Application (2020-2025)
Table 16. Global Pet Veterinary Drug Revenue by Application (2020-2025) & ($ million)
Table 17. Global Pet Veterinary Drug Revenue Market Share by Application (2020-2025)
Table 18. Global Pet Veterinary Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Pet Veterinary Drug Sales by Company (2020-2025) & (K Units)
Table 20. Global Pet Veterinary Drug Sales Market Share by Company (2020-2025)
Table 21. Global Pet Veterinary Drug Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Pet Veterinary Drug Revenue Market Share by Company (2020-2025)
Table 23. Global Pet Veterinary Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Pet Veterinary Drug Producing Area Distribution and Sales Area
Table 25. Players Pet Veterinary Drug Products Offered
Table 26. Pet Veterinary Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Pet Veterinary Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 30. Global Pet Veterinary Drug Sales Market Share Geographic Region (2020-2025)
Table 31. Global Pet Veterinary Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Pet Veterinary Drug Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Pet Veterinary Drug Sales by Country/Region (2020-2025) & (K Units)
Table 34. Global Pet Veterinary Drug Sales Market Share by Country/Region (2020-2025)
Table 35. Global Pet Veterinary Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Pet Veterinary Drug Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Pet Veterinary Drug Sales by Country (2020-2025) & (K Units)
Table 38. Americas Pet Veterinary Drug Sales Market Share by Country (2020-2025)
Table 39. Americas Pet Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 41. Americas Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 42. APAC Pet Veterinary Drug Sales by Region (2020-2025) & (K Units)
Table 43. APAC Pet Veterinary Drug Sales Market Share by Region (2020-2025)
Table 44. APAC Pet Veterinary Drug Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 46. APAC Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 47. Europe Pet Veterinary Drug Sales by Country (2020-2025) & (K Units)
Table 48. Europe Pet Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 50. Europe Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 51. Middle East & Africa Pet Veterinary Drug Sales by Country (2020-2025) & (K Units)
Table 52. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 54. Middle East & Africa Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Pet Veterinary Drug
Table 56. Key Market Challenges & Risks of Pet Veterinary Drug
Table 57. Key Industry Trends of Pet Veterinary Drug
Table 58. Pet Veterinary Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Pet Veterinary Drug Distributors List
Table 61. Pet Veterinary Drug Customer List
Table 62. Global Pet Veterinary Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 63. Global Pet Veterinary Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Pet Veterinary Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Americas Pet Veterinary Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Pet Veterinary Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 67. APAC Pet Veterinary Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Pet Veterinary Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Europe Pet Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Pet Veterinary Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 71. Middle East & Africa Pet Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Pet Veterinary Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 73. Global Pet Veterinary Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Pet Veterinary Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 75. Global Pet Veterinary Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Boehringer Ingelheim International GmbH Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolios and Specifications
Table 78. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Boehringer Ingelheim International GmbH Main Business
Table 80. Boehringer Ingelheim International GmbH Latest Developments
Table 81. Zoetis Animal Healthcare Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolios and Specifications
Table 83. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Zoetis Animal Healthcare Main Business
Table 85. Zoetis Animal Healthcare Latest Developments
Table 86. Bayer AG Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer AG Pet Veterinary Drug Product Portfolios and Specifications
Table 88. Bayer AG Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Bayer AG Main Business
Table 90. Bayer AG Latest Developments
Table 91. Merck Animal Health Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Animal Health Pet Veterinary Drug Product Portfolios and Specifications
Table 93. Merck Animal Health Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Merck Animal Health Main Business
Table 95. Merck Animal Health Latest Developments
Table 96. Elanco Animal Health Inc. Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolios and Specifications
Table 98. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Elanco Animal Health Inc. Main Business
Table 100. Elanco Animal Health Inc. Latest Developments
Table 101. Virbac Group Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Virbac Group Pet Veterinary Drug Product Portfolios and Specifications
Table 103. Virbac Group Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Virbac Group Main Business
Table 105. Virbac Group Latest Developments
Table 106. Ceva Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Ceva Pet Veterinary Drug Product Portfolios and Specifications
Table 108. Ceva Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Ceva Main Business
Table 110. Ceva Latest Developments
Table 111. Dechra Pharmaceuticals Plc Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolios and Specifications
Table 113. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Dechra Pharmaceuticals Plc Main Business
Table 115. Dechra Pharmaceuticals Plc Latest Developments
Table 116. Vetoquinol Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Vetoquinol Pet Veterinary Drug Product Portfolios and Specifications
Table 118. Vetoquinol Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Vetoquinol Main Business
Table 120. Vetoquinol Latest Developments
Table 121. Orion Corporation Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Orion Corporation Pet Veterinary Drug Product Portfolios and Specifications
Table 123. Orion Corporation Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Orion Corporation Main Business
Table 125. Orion Corporation Latest Developments
Table 1. Pet Veterinary Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pet Veterinary Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-Infectives
Table 4. Major Players of Anti-Inflammatory
Table 5. Major Players of Parasiticides
Table 6. Major Players of Analgesics
Table 7. Major Players of Sedatives
Table 8. Major Players of Others
Table 9. Global Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 10. Global Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Table 11. Global Pet Veterinary Drug Revenue by Type (2020-2025) & ($ million)
Table 12. Global Pet Veterinary Drug Revenue Market Share by Type (2020-2025)
Table 13. Global Pet Veterinary Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Pet Veterinary Drug Sale by Application (2020-2025) & (K Units)
Table 15. Global Pet Veterinary Drug Sale Market Share by Application (2020-2025)
Table 16. Global Pet Veterinary Drug Revenue by Application (2020-2025) & ($ million)
Table 17. Global Pet Veterinary Drug Revenue Market Share by Application (2020-2025)
Table 18. Global Pet Veterinary Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Pet Veterinary Drug Sales by Company (2020-2025) & (K Units)
Table 20. Global Pet Veterinary Drug Sales Market Share by Company (2020-2025)
Table 21. Global Pet Veterinary Drug Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Pet Veterinary Drug Revenue Market Share by Company (2020-2025)
Table 23. Global Pet Veterinary Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Pet Veterinary Drug Producing Area Distribution and Sales Area
Table 25. Players Pet Veterinary Drug Products Offered
Table 26. Pet Veterinary Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Pet Veterinary Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 30. Global Pet Veterinary Drug Sales Market Share Geographic Region (2020-2025)
Table 31. Global Pet Veterinary Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Pet Veterinary Drug Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Pet Veterinary Drug Sales by Country/Region (2020-2025) & (K Units)
Table 34. Global Pet Veterinary Drug Sales Market Share by Country/Region (2020-2025)
Table 35. Global Pet Veterinary Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Pet Veterinary Drug Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Pet Veterinary Drug Sales by Country (2020-2025) & (K Units)
Table 38. Americas Pet Veterinary Drug Sales Market Share by Country (2020-2025)
Table 39. Americas Pet Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 41. Americas Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 42. APAC Pet Veterinary Drug Sales by Region (2020-2025) & (K Units)
Table 43. APAC Pet Veterinary Drug Sales Market Share by Region (2020-2025)
Table 44. APAC Pet Veterinary Drug Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 46. APAC Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 47. Europe Pet Veterinary Drug Sales by Country (2020-2025) & (K Units)
Table 48. Europe Pet Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 50. Europe Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 51. Middle East & Africa Pet Veterinary Drug Sales by Country (2020-2025) & (K Units)
Table 52. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Pet Veterinary Drug Sales by Type (2020-2025) & (K Units)
Table 54. Middle East & Africa Pet Veterinary Drug Sales by Application (2020-2025) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Pet Veterinary Drug
Table 56. Key Market Challenges & Risks of Pet Veterinary Drug
Table 57. Key Industry Trends of Pet Veterinary Drug
Table 58. Pet Veterinary Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Pet Veterinary Drug Distributors List
Table 61. Pet Veterinary Drug Customer List
Table 62. Global Pet Veterinary Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 63. Global Pet Veterinary Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Pet Veterinary Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Americas Pet Veterinary Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Pet Veterinary Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 67. APAC Pet Veterinary Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Pet Veterinary Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Europe Pet Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Pet Veterinary Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 71. Middle East & Africa Pet Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Pet Veterinary Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 73. Global Pet Veterinary Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Pet Veterinary Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 75. Global Pet Veterinary Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Boehringer Ingelheim International GmbH Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolios and Specifications
Table 78. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Boehringer Ingelheim International GmbH Main Business
Table 80. Boehringer Ingelheim International GmbH Latest Developments
Table 81. Zoetis Animal Healthcare Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolios and Specifications
Table 83. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Zoetis Animal Healthcare Main Business
Table 85. Zoetis Animal Healthcare Latest Developments
Table 86. Bayer AG Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer AG Pet Veterinary Drug Product Portfolios and Specifications
Table 88. Bayer AG Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Bayer AG Main Business
Table 90. Bayer AG Latest Developments
Table 91. Merck Animal Health Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Animal Health Pet Veterinary Drug Product Portfolios and Specifications
Table 93. Merck Animal Health Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Merck Animal Health Main Business
Table 95. Merck Animal Health Latest Developments
Table 96. Elanco Animal Health Inc. Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolios and Specifications
Table 98. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Elanco Animal Health Inc. Main Business
Table 100. Elanco Animal Health Inc. Latest Developments
Table 101. Virbac Group Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Virbac Group Pet Veterinary Drug Product Portfolios and Specifications
Table 103. Virbac Group Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Virbac Group Main Business
Table 105. Virbac Group Latest Developments
Table 106. Ceva Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Ceva Pet Veterinary Drug Product Portfolios and Specifications
Table 108. Ceva Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Ceva Main Business
Table 110. Ceva Latest Developments
Table 111. Dechra Pharmaceuticals Plc Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolios and Specifications
Table 113. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Dechra Pharmaceuticals Plc Main Business
Table 115. Dechra Pharmaceuticals Plc Latest Developments
Table 116. Vetoquinol Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Vetoquinol Pet Veterinary Drug Product Portfolios and Specifications
Table 118. Vetoquinol Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Vetoquinol Main Business
Table 120. Vetoquinol Latest Developments
Table 121. Orion Corporation Basic Information, Pet Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Orion Corporation Pet Veterinary Drug Product Portfolios and Specifications
Table 123. Orion Corporation Pet Veterinary Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Orion Corporation Main Business
Table 125. Orion Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet Veterinary Drug
Figure 2. Pet Veterinary Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Veterinary Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pet Veterinary Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pet Veterinary Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pet Veterinary Drug Sales Market Share by Country/Region (2024)
Figure 10. Pet Veterinary Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Anti-Infectives
Figure 12. Product Picture of Anti-Inflammatory
Figure 13. Product Picture of Parasiticides
Figure 14. Product Picture of Analgesics
Figure 15. Product Picture of Sedatives
Figure 16. Product Picture of Others
Figure 17. Global Pet Veterinary Drug Sales Market Share by Type in 2025
Figure 18. Global Pet Veterinary Drug Revenue Market Share by Type (2020-2025)
Figure 19. Pet Veterinary Drug Consumed in Veterinary Hospitals
Figure 20. Global Pet Veterinary Drug Market: Veterinary Hospitals (2020-2025) & (K Units)
Figure 21. Pet Veterinary Drug Consumed in Veterinary Clinics
Figure 22. Global Pet Veterinary Drug Market: Veterinary Clinics (2020-2025) & (K Units)
Figure 23. Pet Veterinary Drug Consumed in Drug Stores
Figure 24. Global Pet Veterinary Drug Market: Drug Stores (2020-2025) & (K Units)
Figure 25. Global Pet Veterinary Drug Sale Market Share by Application (2024)
Figure 26. Global Pet Veterinary Drug Revenue Market Share by Application in 2025
Figure 27. Pet Veterinary Drug Sales by Company in 2025 (K Units)
Figure 28. Global Pet Veterinary Drug Sales Market Share by Company in 2025
Figure 29. Pet Veterinary Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Pet Veterinary Drug Revenue Market Share by Company in 2025
Figure 31. Global Pet Veterinary Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Pet Veterinary Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 34. Americas Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 36. APAC Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 38. Europe Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Pet Veterinary Drug Sales Market Share by Country in 2025
Figure 42. Americas Pet Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 44. Americas Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Pet Veterinary Drug Sales Market Share by Region in 2025
Figure 50. APAC Pet Veterinary Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 52. APAC Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 53. China Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Pet Veterinary Drug Sales Market Share by Country in 2025
Figure 61. Europe Pet Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 63. Europe Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. France Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Pet Veterinary Drug in 2025
Figure 78. Manufacturing Process Analysis of Pet Veterinary Drug
Figure 79. Industry Chain Structure of Pet Veterinary Drug
Figure 80. Channels of Distribution
Figure 81. Global Pet Veterinary Drug Sales Market Forecast by Region (2026-2031)
Figure 82. Global Pet Veterinary Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Pet Veterinary Drug Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Pet Veterinary Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Pet Veterinary Drug Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Pet Veterinary Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Pet Veterinary Drug
Figure 2. Pet Veterinary Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Veterinary Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pet Veterinary Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pet Veterinary Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pet Veterinary Drug Sales Market Share by Country/Region (2024)
Figure 10. Pet Veterinary Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Anti-Infectives
Figure 12. Product Picture of Anti-Inflammatory
Figure 13. Product Picture of Parasiticides
Figure 14. Product Picture of Analgesics
Figure 15. Product Picture of Sedatives
Figure 16. Product Picture of Others
Figure 17. Global Pet Veterinary Drug Sales Market Share by Type in 2025
Figure 18. Global Pet Veterinary Drug Revenue Market Share by Type (2020-2025)
Figure 19. Pet Veterinary Drug Consumed in Veterinary Hospitals
Figure 20. Global Pet Veterinary Drug Market: Veterinary Hospitals (2020-2025) & (K Units)
Figure 21. Pet Veterinary Drug Consumed in Veterinary Clinics
Figure 22. Global Pet Veterinary Drug Market: Veterinary Clinics (2020-2025) & (K Units)
Figure 23. Pet Veterinary Drug Consumed in Drug Stores
Figure 24. Global Pet Veterinary Drug Market: Drug Stores (2020-2025) & (K Units)
Figure 25. Global Pet Veterinary Drug Sale Market Share by Application (2024)
Figure 26. Global Pet Veterinary Drug Revenue Market Share by Application in 2025
Figure 27. Pet Veterinary Drug Sales by Company in 2025 (K Units)
Figure 28. Global Pet Veterinary Drug Sales Market Share by Company in 2025
Figure 29. Pet Veterinary Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Pet Veterinary Drug Revenue Market Share by Company in 2025
Figure 31. Global Pet Veterinary Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Pet Veterinary Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 34. Americas Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 36. APAC Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 38. Europe Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Pet Veterinary Drug Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Pet Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Pet Veterinary Drug Sales Market Share by Country in 2025
Figure 42. Americas Pet Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 44. Americas Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Pet Veterinary Drug Sales Market Share by Region in 2025
Figure 50. APAC Pet Veterinary Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 52. APAC Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 53. China Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Pet Veterinary Drug Sales Market Share by Country in 2025
Figure 61. Europe Pet Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 63. Europe Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. France Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Pet Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Pet Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Pet Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Pet Veterinary Drug in 2025
Figure 78. Manufacturing Process Analysis of Pet Veterinary Drug
Figure 79. Industry Chain Structure of Pet Veterinary Drug
Figure 80. Channels of Distribution
Figure 81. Global Pet Veterinary Drug Sales Market Forecast by Region (2026-2031)
Figure 82. Global Pet Veterinary Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Pet Veterinary Drug Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Pet Veterinary Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Pet Veterinary Drug Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Pet Veterinary Drug Revenue Market Share Forecast by Application (2026-2031)
